HC Wainwright & Co. Reiterates Buy on Biomea Fusion, Maintains $15 Price Target
Portfolio Pulse from Benzinga Newsdesk
HC Wainwright & Co. has reiterated its Buy rating on Biomea Fusion (NASDAQ:BMEA) and maintained a price target of $15.
August 01, 2024 | 1:16 pm
News sentiment analysis
Sort by:
Ascending
POSITIVE IMPACT
HC Wainwright & Co. has reiterated its Buy rating on Biomea Fusion and maintained a price target of $15.
The reiteration of a Buy rating and the maintenance of a $15 price target by HC Wainwright & Co. is a positive signal for investors, likely boosting short-term confidence and potentially driving the stock price up.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100